Structural Optimization and Biological Evaluation of 1-Adamantylcarbonyl-4-phenylpiperazine Derivatives As FXR Agonists for NAFLD.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY（2023）
Key words
FXR agonists,Non-alcoholic fatty liver disease,Structural optimization,Molecular dynamics simulation,Hepatic steatosis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined